Lillian R Meacham

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Characteristics of growth hormone therapy for pediatric patients with brain tumors in the National Cooperative Growth Study (NCGS) and from a survey of pediatric endocrinologists
    Lillian R Meacham
    Emory University and Children s Healthcare of Atlanta, GA 30033, USA
    J Pediatr Endocrinol Metab 15:689-96. 2002
  2. ncbi Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study
    Lillian R Meacham
    AFLAC Cancer Center, Emory University, Hematology Oncology and Endocrinology, 2015 Uppergate Drive Northeast, Atlanta, GA 30322, USA
    Cancer Epidemiol Biomarkers Prev 19:170-81. 2010
  3. ncbi Auxologic and biochemical characterization of the three phases of growth failure in pediatric patients with brain tumors
    Lillian R Meacham
    Division of Pediatric Endocrinology, Emory University and AFLAC Cancer Center of Children s Healthcare of Atlanta, Atlanta, GA 30322, USA
    J Pediatr Endocrinol Metab 17:711-7. 2004
  4. ncbi Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study
    Lillian R Meacham
    Department of Pediatrics, Emory University, Atlanta, Georgia, USA
    Arch Intern Med 169:1381-8. 2009
  5. ncbi Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study
    Lillian R Meacham
    Department of Pediatrics, Emory University, Atlanta, Georgia 30322, USA
    Cancer 103:1730-9. 2005
  6. ncbi Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study
    Karen Wasilewski-Masker
    Aflac Cancer Center and Blood Disorders Service, Children s Healthcare of Atlanta at Scottish Rite, 5455 Meridian Mark Rd, Ste 400, Atlanta, GA 30342, USA
    J Natl Cancer Inst 101:1709-20. 2009
  7. ncbi Adrenal function testing in pediatric cancer survivors
    Briana C Patterson
    Division of Endocrinology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 53:1302-7. 2009
  8. ncbi Severity of health conditions identified in a pediatric cancer survivor program
    Karen Wasilewski-Masker
    The Aflac Cancer Center and Blood Disorders Service at Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30342, USA
    Pediatr Blood Cancer 54:976-82. 2010
  9. ncbi Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature
    Karen Wasilewski-Masker
    Division of Pediatric Hematology Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Pediatrics 121:e705-13. 2008
  10. ncbi Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia
    Della L Howell
    Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Service, Children s Healthcare of Atlanta, Atlanta, Georgia 30322, USA
    Pediatr Blood Cancer 49:349-52. 2007

Detail Information

Publications16

  1. ncbi Characteristics of growth hormone therapy for pediatric patients with brain tumors in the National Cooperative Growth Study (NCGS) and from a survey of pediatric endocrinologists
    Lillian R Meacham
    Emory University and Children s Healthcare of Atlanta, GA 30033, USA
    J Pediatr Endocrinol Metab 15:689-96. 2002
    ..The time to initiating GH replacement therapy was evaluated in 14 tumor types, as well as the contributing impact of the extent of tumor resection...
  2. ncbi Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study
    Lillian R Meacham
    AFLAC Cancer Center, Emory University, Hematology Oncology and Endocrinology, 2015 Uppergate Drive Northeast, Atlanta, GA 30322, USA
    Cancer Epidemiol Biomarkers Prev 19:170-81. 2010
    ..Childhood cancer survivors are at higher risk of morbidity and mortality from cardiovascular disease compared with the general population...
  3. ncbi Auxologic and biochemical characterization of the three phases of growth failure in pediatric patients with brain tumors
    Lillian R Meacham
    Division of Pediatric Endocrinology, Emory University and AFLAC Cancer Center of Children s Healthcare of Atlanta, Atlanta, GA 30322, USA
    J Pediatr Endocrinol Metab 17:711-7. 2004
    ..Phase 1 is characterized by decreased HV, BMI, leptin levels and calorie counts. With recognition of this profile, the early growth failure might be preventable with aggressive nutritional rehabilitation...
  4. ncbi Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study
    Lillian R Meacham
    Department of Pediatrics, Emory University, Atlanta, Georgia, USA
    Arch Intern Med 169:1381-8. 2009
    ..Childhood cancer survivors are at increased risk of morbidity and mortality. To further characterize this risk, this study aimed to compare the prevalence of diabetes mellitus (DM) in childhood cancer survivors and their siblings...
  5. ncbi Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study
    Lillian R Meacham
    Department of Pediatrics, Emory University, Atlanta, Georgia 30322, USA
    Cancer 103:1730-9. 2005
    ..The goals of the current study were to determine the distribution of body mass index (BMI) of survivors of common pediatric malignancies and to identify factors associated with abnormal BMI...
  6. ncbi Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study
    Karen Wasilewski-Masker
    Aflac Cancer Center and Blood Disorders Service, Children s Healthcare of Atlanta at Scottish Rite, 5455 Meridian Mark Rd, Ste 400, Atlanta, GA 30342, USA
    J Natl Cancer Inst 101:1709-20. 2009
    ..We sought to estimate late recurrence rates for the most common pediatric cancers and to determine risk factors for late recurrence...
  7. ncbi Adrenal function testing in pediatric cancer survivors
    Briana C Patterson
    Division of Endocrinology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 53:1302-7. 2009
    ..Central adrenal insufficiency is observed after cranial radiation therapy for cancer. Screening at risk patients is recommended, but the best screening strategy is unknown...
  8. ncbi Severity of health conditions identified in a pediatric cancer survivor program
    Karen Wasilewski-Masker
    The Aflac Cancer Center and Blood Disorders Service at Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30342, USA
    Pediatr Blood Cancer 54:976-82. 2010
    ..0 (CTCAE) was designed for reporting acute and late effects of cancer treatment. To date, no study of pediatric-aged cancer survivors has graded health conditions using CTCAE, for patients in active follow-up in a cancer survivor program...
  9. ncbi Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature
    Karen Wasilewski-Masker
    Division of Pediatric Hematology Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Pediatrics 121:e705-13. 2008
    ....
  10. ncbi Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia
    Della L Howell
    Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Service, Children s Healthcare of Atlanta, Atlanta, Georgia 30322, USA
    Pediatr Blood Cancer 49:349-52. 2007
    ..The first twin was treated for high-risk leukemia and the second for standard-risk leukemia, each with different ALL protocols. Timely use of the LTFU guidelines has aided in identifying and treating their adverse late effects...
  11. ncbi Seventeen-year-old adolescent with pituitary abscess
    Michelle I Lin
    Division of Pediatric Endocrinology, Emory Children s Center, 2015 Uppergate Drive, Atlanta, GA 30322, USA
    J Pediatr Endocrinol Metab 24:771-3. 2011
    ..He continues to require thyroid, adrenal and anti-diuretic hormone replacements. As with any pituitary lesion, prompt complete hypothalamic pituitary evaluation is essential to avoid potentially life-threatening consequences...
  12. ncbi Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer
    Lillian R Meacham
    Department of Pediatrics, Emory University, AFLAC Cancer Center, Blood Disorders Service, Children s Healthcare of Atlanta, Georgia, USA
    J Pediatr Hematol Oncol 25:414-7. 2003
    ..The suppression of the adrenal axis was at the level of the hypothalamus/pituitary. Adrenal suppression can occur in patients treated with MA. Awareness of this possibility and the use of glucocorticoid stress coverage are advised...
  13. ncbi Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
    Edward G Garmey
    Department of Pediatrics and Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 26:4639-45. 2008
    ..We examined the rate of increase in the body mass index (BMI; kg/m(2)) after final height attainment in survivors of acute lymphoblastic leukemia (ALL) and a noncancer comparison group...
  14. ncbi Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study
    Nina S Kadan-Lottick
    Section of Pediatric Hematology Oncology, Yale University School of Medicine, New Haven, CT 06520, USA
    J Clin Oncol 26:3038-45. 2008
    ..Osteonecrosis (ON) is a potentially serious complication of therapy in survivors of childhood cancer. Our goals were to describe the incidence of ON and identify patient and treatment characteristics associated with elevated risk...
  15. ncbi Obesity in pediatric oncology
    Paul C Rogers
    Children s and Women s Hospital and University of British Columbia, Vancouver, British Columbia, Canada
    Pediatr Blood Cancer 45:881-91. 2005
    ....
  16. ncbi The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma
    Patrick W Mason
    Inova Fairfax Hospital for Children, Fairfax, VA, USA
    Arch Pediatr Adolesc Med 156:887-92. 2002
    ..Further studies are needed to determine if the improvements are stable and if earlier intervention can prevent the initial obesity...